As of November 7, 2026, Myriad Genetics Inc. is a publicly traded company (Nasdaq: MYGN); its largest reported holder is BlackRock, with 8.6% on Schedule 13G/A of October 27, 2026, then BlackRock (8.5%). The largest insider holding is Samraat S. Raha, the chief executive and president, with 1,068,083 shares (1.1% of shares outstanding), per Form 4 of June 12, 2026 (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Myriad Genetics Inc.? See the free Snapshot first.
Free to see. No signup.
Is Myriad Genetics Inc. a real, registered company?
- Myriad Genetics Inc files with the SEC under CIK 899923 (its SEC filings).
- Its shares are listed under the ticker MYGN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Salt Lake City, Utah, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under MYRIAD GENETICS INC in our court records and SEC 8-K records (as of 2026-11-07).
- Leadership changes: the latest reported is Vishal Sikri, Senior Vice President, Product (Form 8-K filed 2026-09-16). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Myriad Genetics Inc.'s owners and officers?
Myriad Genetics Inc.: incorporated in Delaware; business address in Salt Lake City, Utah; industry In Vitro & In Vivo Diagnostic Substances (Schedule 13G/A, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-27 | Blackrock Portfolio Management LLC | 8.6% |
| Schedule 13G, 2026-09-04 | Blackrock Portfolio Management LLC | 10.4% |
| Schedule 13G/A, 2026-08-14 | Glenview Capital Management, LLC | 0% |
| Schedule 13G, 2026-08-14 | Vestal Point Capital, LP | 6.1% |
| Schedule 13G, 2026-08-07 | State Street Corporation | 5.3% |
| Schedule 13G, 2026-05-12 | State Street Corporation | 4.7% |
| Schedule 13G/A, 2026-04-07 | Blackrock, Inc. | 8.5% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-11 | Millennium Management LLC | 7.2% |
| Schedule 13G, 2026-02-09 | State Street Corporation | 6.4% |
| Schedule 13G, 2026-01-13 | Glenview Capital Management, LLC | 5.3% |
| Schedule 13G/A, 2025-11-12 | Barclays PLC | 4.23% |
Questions about who owns Myriad Genetics Inc.
Who owns Myriad Genetics Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of Myriad Genetics Inc.: Blackrock Portfolio Management LLC (8.6%, Schedule 13G/A, filed 2026-10-27), Blackrock, Inc. (8.5%, Schedule 13G/A, filed 2026-04-07), Millennium Management LLC (7.2%, Schedule 13G/A, filed 2026-02-11), Vestal Point Capital, LP (6.1%, Schedule 13G, filed 2026-08-14) and State Street Corporation (5.3%, Schedule 13G, filed 2026-08-07).
Who are the largest shareholders of Myriad Genetics Inc.?
By the share each holder's latest filing reports, the largest holders of Myriad Genetics Inc. on this page are Blackrock Portfolio Management LLC (8.6%), Blackrock, Inc. (8.5%) and Millennium Management LLC (7.2%).
When did Blackrock Portfolio Management LLC buy into Myriad Genetics Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock Portfolio Management LLC on this page is the Schedule 13G, filed 2026-09-04, reporting 10.4%; its latest, Schedule 13G/A filed 2026-10-27, reports 8.6%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Myriad Genetics Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Myriad Genetics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Myriad Genetics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-16 | Vishal Sikri | Senior Vice President, Product | appointed | 2026-09-16 |
Which insiders own Myriad Genetics Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 1,068,083 shares (1.1% of shares outstanding) (Form 4, 2026-06-12).
- , the chief executive and president: 891,844 shares (0.93% of shares outstanding) (Form 4, 2025-04-30).
- , the chief operating officer: 629,646 shares (0.66% of shares outstanding) (Form 4, 2026-04-15).
- , the chief commercial officer: 573,363 shares (0.60% of shares outstanding) (Form 4, 2026-09-18).
- , the executive vice president and commercial: 351,224 shares (0.37% of shares outstanding) (Form 4, 2026-09-17).
Shares outstanding: 95,922,196 as of 2026-10-30, from the company's latest SEC cover page.
How much has Myriad Genetics Inc. raised?
No fundraising or offering filing from Myriad Genetics Inc. is on file with us.
Keep reading
More on Myriad Genetics Inc. and the records around it.
Myriad Genetics Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Sep 2026
Companies that share a holder
- GLENVIEW CAPITAL MANAGEMENT, LLC also filed stake reports on 6 other companies: Surgery Partners, Inc. (Oct 2026), Butterfly Network, Inc. (Aug 2026), DXC Technology Co (Aug 2026)
- DISCIPLINED GROWTH INVESTORS INC /MN also filed stake reports on 10 other companies: Alarm.com Holdings, Inc. (Aug 2026), Kornit Digital Ltd. (Aug 2026), Stitch Fix, Inc. (Aug 2026)
- Vestal Point Capital, LP also filed stake reports on 27 other companies: Alto Neuroscience, Inc. (Aug 2026), iBio, Inc. (Aug 2026), Immunocore Holdings plc (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/myriad-genetics